Psychopharmacology explores the effects of drugs on the human mind and behavior, with a focus on pharmacodynamics—the study of how drugs interact with the body. In this field, researchers investigate the mechanisms by which psychoactive substances exert their influence on the central nervous system. Pharmacodynamics delves into the drug-receptor interactions, signal transduction pathways, and molecular alterations that underlie the physiological and psychological responses to medications. Understanding pharmacodynamics is crucial in tailoring drug therapies for mental health disorders, as it helps elucidate the specific targets and modes of action that contribute to therapeutic effects or potential side effects. Researchers in psychopharmacology strive to unravel the intricate relationships between drugs and neural processes, aiming to enhance the precision and efficacy of pharmacological interventions for conditions like depression, anxiety, and psychosis. As the field evolves, a deeper comprehension of pharmacodynamics promises to pave the way for more targeted and personalized approaches to mental health treatment.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico